Biodesix, Inc. provided revenue guidance for the year 2024. The company anticipates generating between $65 million to $68 million in total revenue in 2024, representing an approximate 32% to 39% year-over-year growth rate.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.575 USD | +0.96% | -0.32% | -14.40% |
May. 13 | TD Cowen Starts Biodesix With Buy Rating, $2.80 Price Target | MT |
May. 08 | Transcript : Biodesix, Inc., Q1 2024 Earnings Call, May 08, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-14.40% | 179M | |
-17.05% | 8.55B | |
+65.23% | 4.24B | |
-1.63% | 2.53B | |
-9.81% | 2.44B | |
-41.76% | 2.35B | |
-8.53% | 1.89B | |
-19.29% | 1.55B | |
-39.61% | 1.23B | |
+9.68% | 1.13B |
- Stock Market
- Equities
- BDSX Stock
- News Biodesix, Inc.
- Biodesix, Inc. Provides Revenue Guidance for the Year 2024